Cite
Durand-Reville TF, Miller AA, O'Donnell JP, et al. Rational design of a new antibiotic class for drug-resistant infections. Nature. 2021;597(7878):698-702doi: 10.1038/s41586-021-03899-0.
Durand-Reville, T. F., Miller, A. A., O'Donnell, J. P., Wu, X., Sylvester, M. A., Guler, S., Iyer, R., Shapiro, A. B., Carter, N. M., Velez-Vega, C., Moussa, S. H., McLeod, S. M., Chen, A., Tanudra, A. M., Zhang, J., Comita-Prevoir, J., Romero, J. A., Huynh, H., Ferguson, A. D., Horanyi, P. S., Mayclin, S. J., Heine, H. S., Drusano, G. L., Cummings, J. E., Slayden, R. A., & Tommasi, R. A. (2021). Rational design of a new antibiotic class for drug-resistant infections. Nature, 597(7878), 698-702. https://doi.org/10.1038/s41586-021-03899-0
Durand-Reville, Thomas F, et al. "Rational design of a new antibiotic class for drug-resistant infections." Nature vol. 597,7878 (2021): 698-702. doi: https://doi.org/10.1038/s41586-021-03899-0
Durand-Reville TF, Miller AA, O'Donnell JP, Wu X, Sylvester MA, Guler S, Iyer R, Shapiro AB, Carter NM, Velez-Vega C, Moussa SH, McLeod SM, Chen A, Tanudra AM, Zhang J, Comita-Prevoir J, Romero JA, Huynh H, Ferguson AD, Horanyi PS, Mayclin SJ, Heine HS, Drusano GL, Cummings JE, Slayden RA, Tommasi RA. Rational design of a new antibiotic class for drug-resistant infections. Nature. 2021 Sep;597(7878):698-702. doi: 10.1038/s41586-021-03899-0. Epub 2021 Sep 15. PMID: 34526714.
Copy
Download .nbib